Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070)
Clinical trial NCT01512693 · COMPLETED
Trial details
- NCT number
- NCT01512693
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-23
- Primary completion
- 2012-04-24
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.